Growth Metrics

Bruker (BRKR) Common Equity (2016 - 2026)

Bruker filings provide 17 years of Common Equity readings, the most recent being $2.5 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 37.91% to $2.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 billion, a 37.91% increase, with the full-year FY2025 number at $2.5 billion, up 37.91% from a year prior.
  • Common Equity hit $2.5 billion in Q4 2025 for Bruker, up from $2.4 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $2.5 billion in Q4 2025 to a low of $948.0 million in Q3 2022.
  • Median Common Equity over the past 5 years was $1.2 billion (2023), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Common Equity: fell 13.0% in 2022 and later skyrocketed 48.73% in 2024.
  • Bruker's Common Equity stood at $1.1 billion in 2021, then increased by 3.79% to $1.1 billion in 2022, then rose by 23.89% to $1.4 billion in 2023, then grew by 27.72% to $1.8 billion in 2024, then soared by 37.91% to $2.5 billion in 2025.
  • The last three reported values for Common Equity were $2.5 billion (Q4 2025), $2.4 billion (Q3 2025), and $1.8 billion (Q2 2025) per Business Quant data.